Repligen Cp (RGEN)
$87.61 0.41 (0.47%)
11:54 EDT RGEN Stock Quote Delayed 15 Minutes
Previous Close $87.20
Market Cap 3.83B
PE Ratio 123.39
Volume (Avg. Vol.) 137,768
Day's Range 86.99 - 88.01
52-Week Range 45.00 - 89.22
Dividend & Yield N/A (N/A)
RGEN Stock Predictions, Articles, and Repligen Cp News
- From InvestorPlace
- From the Web
Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
With an aging population, pharma stocks can be a very profitable investments. These 5 biotechs probably aren't.
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The following stocks were moving the Manufacturing sector today.
This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Healthcare stocks rose broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.3%.
Healthcare stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.6%.
Healthcare stocks remained flat on Monday morning on Wall Street.
Healthcare stocks fell on Wall Street on Thursday morning, down 0.3%.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks declined on Wall Street on Tuesday morning, down 0.6%.
Healthcare stocks fell on Wall Street on Friday morning, down 0.6%.
Healthcare stocks fell broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 0.2%.
From Market News Video
From Simply Wall St
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! While some investors are already well versed<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgen/repligen/news/should-you-be-concerned-about-repligen-corporations-nasdaqrgen-roe/">Read More...</a></div>
From Seeking Alpha
From Market News Video
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!